NCT07619274

Brief Summary

Right heart dysfunction remains a frequent cause of morbidity and mortality after cardiac surgery. Respiratory acidosis, particularly when accompanied by hypoxemia, plays a significant role in right heart failure, primarily by increasing right ventricular afterload through pulmonary vasoconstriction and elevated pulmonary arterial pressures. This phenomenon leads to increased right ventricular workload, causing dilation, decreased contractility, and ultimately right heart failure. The study aims to evaluate the effect of respiratory acidosis on right ventricular function after cardiac surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
3mo left

Started May 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
May 2026Oct 2026

Study Start

First participant enrolled

May 1, 2026

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 8, 2026

Completed
24 days until next milestone

First Posted

Study publicly available on registry

June 1, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

June 1, 2026

Status Verified

May 1, 2026

Enrollment Period

3 months

First QC Date

May 8, 2026

Last Update Submit

May 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Right ventricular function per central hemodynamic assessment

    Calculation of different predictor: Cardiac index, PAPi (pulmonary artery pulse pressure over central venous pressure) , RVSWI ((mean pulmonary artery pressure- central venous pressure) X stroke volume index X 0.0136) and RV-CPO

    At intensive care unit admission - within the first 4 hours

Secondary Outcomes (5)

  • Intensive care unit length of stay

    Up to 28 days

  • Mechanical ventilation duration

    Day 28

  • Vasopressor duration

    Day 28

  • Acute renal failure

    Day 28

  • Mortality

    Day 28

Study Arms (2)

Retrospective cohort

Completed study. Adult patients who underwent cardiac surgery were included if they were admitted to the intensive care unit immediately after surgery, mechanically ventilated in controlled mode, and had an arterial blood gas within the first hour following admission.

Other: Not applicable- observational study

Prospective cohort

Completed study. Adult patient included on open-label randomized study, comparing clinician-chosen initial mechanical ventilation parameters to those recommended by an algorithm immediately after ICU admission.

Other: Not applicable- observational study

Interventions

No intervention

Prospective cohortRetrospective cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients who underwent cardiac surgery mechanically ventilated in controlled mode, and had an arterial blood gas within the first hour following admission.

You may qualify if:

  • Previously included and complete study NCT05886413 or NCT06826794

You may not qualify if:

  • Absence of one or more of the following hemodynamic measurements: systolic or diastolic pulmonary artery pressure, central venous pressure, cardiac output
  • Absence of arterial blood gas on arrival to the intensive care unit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval

Québec, Quebec, G1V4G5, Canada

Location

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co-Investigator

Study Record Dates

First Submitted

May 8, 2026

First Posted

June 1, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

June 1, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations